文献速递产科生殖医学

子宫内膜异位症和/或使用辅助生殖技术女性的妊娠结局:一项基于人群的队列研究

Pregnancy outcomes in women with endometriosis and/or ART use: a population-based cohort study.
PubMed 文献 · Hum Reprod · 2022-01-01

该基于人群的队列研究纳入2006-2015年澳大利亚新南威尔士州578221例单胎妊娠,比较无内异症/无ART、无内异症/ART、内异症/无ART、内异症/ART四组的妊娠结局。结果显示内异症与ART使用均与早产、产前出血、前置胎盘和计划分娩风险升高相关。

要点

  • 内异症与ART使用均与早产、产前出血、前置胎盘和计划分娩风险升高相关。
  • 内异症合并ART组早产aRR 1.93(99% CI 1.11-3.35),产前出血aRR 2.69(99% CI 1.30-5.56)。
  • 内异症无ART组大于胎龄儿风险降低(aRR 0.83,99% CI 0.73-0.94)。

核心结论

  • 内异症和ART使用均与早产、产前出血、前置胎盘和计划分娩风险升高相关,提示此类女性为高危产科人群。

研究设计与样本

  • 基于人群的队列研究,纳入2006-2015年澳大利亚新南威尔士州578221例年龄15-45岁女性的单胎妊娠(孕周≥20周或出生体重≥400g),分为无内异症/无ART、无内异症/ART、内异症/无ART、内异症/ART四组。

主要发现

  • 与无内异症且无ART的妊娠相比,早产(<37周)风险在无内异症/ART组aRR 1.85(99% CI 1.46-2.34)、内异症/无ART组aRR 1.24(99% CI 1.06-1.44)、内异症/ART组aRR 1.93(99% CI 1.11-3.35)均升高。
  • 产前出血风险在无内异症/ART组aRR 1.99(99% CI 1.39-2.85)、内异症/无ART组aRR 1.31(99% CI 1.03-1.67)、内异症/ART组aRR 2.69(99% CI 1.30-5.56)均升高。
  • 前置胎盘风险在无内异症/ART组aRR 2.26(99% CI 1.42-3.60)、内异症/无ART组aRR 1.66(99% CI 1.18-2.33)升高;计划分娩风险在无内异症/ART组aRR 1.08(99% CI 1.03-1.14)、内异症/无ART组aRR 1.11(99% CI 1.07-1.14)升高。
  • 无内异症/ART组胎盘早剥aRR 2.36(99% CI 1.12-4.98)、母亲并发症aRR 1.67(99% CI 1.07-2.62)、低出生体重(<2500g)aRR 1.45(99% CI 1.09-1.93)风险升高;内异症/无ART组大于胎龄儿风险降低(aRR 0.83,99% CI 0.73-0.94)。

临床怎么用

  • 作者认为,内异症女性包括使用ART妊娠者属于高危产科人群,孕期需要适当的监测和管理。

局限性

  • 内异症常诊断不足,有医院内异症诊断史的女性可能代表症状更明显或病情更严重者。
  • 若内异症对妊娠的影响在病情更严重者中更大,本研究结果可能在人群水平上高估内异症对不良妊娠结局的影响。
  • 无法评估内异症分期或类型对研究结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the association between endometriosis and adverse pregnancy outcomes with ART use and non-use? SUMMARY ANSWER: Endometriosis and ART use are both associated with increased risk of preterm birth, antepartum haemorrhage, placenta praevia and planned birth (caesarean delivery or induction of labour). WHAT IS KNOWN ALREADY: There are contradictory findings on the association between endometriosis and adverse pregnancy outcomes, and many large studies have not considered the effect of ART use. STUDY DESIGN, SIZE, DURATION: Population-based cohort study of 578 221 eligible pregnancies during 2006-2015, comparing pregnancy outcomes across four groups (No endo/no ART, No endo/ART, Endo/no ART and Endo/ART). PARTICIPANTS/MATERIALS, SETTING, METHODS: All female residents of New South Wales, Australia aged 15-45 years and their index singleton pregnancy of at least 20 weeks gestation or 400 g birthweight. Linked hospital, pregnancy/birth and mortality data were used. Modified Poisson regression with robust error variances was used to estimate adjusted risk ratios (aRRs) and 99% CIs, adjusting for sociodemographic and pregnancy factors. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to women without endometriosis who had pregnancies without ART use, there was increased risk of preterm birth (<37 weeks) in all groups [No endo/ART (aRR 1.85, 99% CI 1.46-2.34), Endo/no ART (aRR 1.24, 99% CI 1.06-1.44), Endo/ART (aRR 1.93, 99% CI 1.11-3.35)] and antepartum haemorrhage [No endo/ART (aRR 1.99, 99% CI 1.39-2.85), Endo/no ART (aRR 1.31, 99% CI 1.03-1.67), Endo/ART (aRR 2.69, 99% CI 1.30-5.56)] among pregnancies affected by endometriosis or ART use, separately and together. There was increased risk of placenta praevia [No endo/ART (aRR 2.26, 99% CI 1.42-3.60), Endo/no ART (aRR 1.66, 99% CI 1.18-2.33)] and planned birth [No endo/ART (aRR 1.08, 99% CI 1.03-1.14), Endo/no ART (aRR 1.11, 99% CI 1.07-1.14)] among pregnancies with endometriosis or ART use, separately. There was increased risk of placental abruption [No endo/ART (aRR 2.36, 99% CI 1.12-4.98)], maternal morbidity [No endo/ART (aRR 1.67, 99% CI 1.07-2.62)] and low birthweight (<2500 g) [No endo/ART (aRR 1.45, 99% CI 1.09-1.93)] among pregnancies with ART use without endometriosis. There was decreased risk of having a large-for-gestational age infant [Endo/no ART (aRR 0.83, 99% CI 0.73-0.94)] among pregnancies with endometriosis without ART use. LIMITATIONS, REASONS FOR CAUTION: Endometriosis is often under-diagnosed and women with a history of hospital diagnosis of endometriosis may represent those with more symptomatic or severe disease. If the effects of endometriosis on pregnancy are greater for those with more severe disease, our results may over-estimate the effect of endometriosis on adverse pregnancy outcomes at a population level. We were unable to assess the effect of endometriosis stage or typology on the study outcomes. WIDER IMPLICATIONS OF THE FINDINGS: These results suggest that women with endometriosis including those who used ART to achieve pregnancy are a higher-risk obstetric group requiring appropriate surveillance and management during their pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Prevention Research Support Program, funded by the New South Wales Ministry of Health. The funder had no role in the design, data collection and analysis, interpretation of results, manuscript preparation or the decision to submit the manuscript for publication. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ibiebele I, Nippita T, Baber R, et al. Pregnancy outcomes in women with endometriosis and/or ART use: a population-based cohort study. Hum Reprod. 2022. PMID: 36018266. doi:10.1093/humrep/deac186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。